Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)
Japan
· Delayed Price · Currency is JPY 335.00
+7.00 (2.13%)
Mar 10, 2026, 2:14 PM JST
Wakamoto Pharmaceutical Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | 2007 - 2003 |
|---|---|---|---|---|---|---|
Period Ending | Mar '12 Mar 31, 2012 | Mar '11 Mar 31, 2011 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 | 2007 - 2003 |
| Cash & Equivalents | 1,464 | 1,222 | 1,303 | 1,252 | 809.24 | Upgrade
|
| Short-Term Investments | 405 | 405 | 645.04 | 1,211 | 2,956 | Upgrade
|
| Cash & Short-Term Investments | 1,869 | 1,627 | 1,948 | 2,463 | 3,765 | Upgrade
|
| Cash Growth | 14.87% | -16.50% | -20.90% | -34.58% | 16.28% | Upgrade
|
| Accounts Receivable | 3,563 | 3,956 | 4,064 | 4,139 | 4,359 | Upgrade
|
| Other Receivables | 2 | 3 | 10.38 | 78.09 | - | Upgrade
|
| Receivables | 3,565 | 3,959 | 4,074 | 4,217 | 4,359 | Upgrade
|
| Inventory | 2,314 | 2,209 | 1,676 | 1,787 | 1,549 | Upgrade
|
| Other Current Assets | 150 | 153 | 108.55 | 111.78 | 105.46 | Upgrade
|
| Total Current Assets | 8,305 | 8,234 | 8,098 | 8,876 | 10,010 | Upgrade
|
| Property, Plant & Equipment | 5,002 | 5,720 | 6,508 | 5,551 | 3,539 | Upgrade
|
| Long-Term Investments | 2,531 | 2,231 | 1,648 | 1,561 | 1,913 | Upgrade
|
| Other Intangible Assets | 408 | 107 | 118.63 | 131.55 | 159.38 | Upgrade
|
| Long-Term Deferred Tax Assets | 602 | 884 | 574.53 | 674.63 | 549.59 | Upgrade
|
| Other Long-Term Assets | 1 | - | 757.85 | 951.41 | 947.08 | Upgrade
|
| Total Assets | 16,849 | 17,176 | 17,705 | 17,745 | 17,118 | Upgrade
|
| Accounts Payable | 1,221 | 1,659 | 1,360 | 1,640 | 1,469 | Upgrade
|
| Accrued Expenses | 192 | 174 | 309.88 | 314.92 | 327 | Upgrade
|
| Short-Term Debt | 323 | 241 | 224.87 | 29.06 | - | Upgrade
|
| Current Income Taxes Payable | 30 | 52 | 20.17 | 130.6 | 86.61 | Upgrade
|
| Other Current Liabilities | 167 | 187 | 245.83 | 1,186 | 528.32 | Upgrade
|
| Total Current Liabilities | 1,933 | 2,313 | 2,161 | 3,300 | 2,411 | Upgrade
|
| Long-Term Debt | 1,334 | 1,230 | 1,426 | - | - | Upgrade
|
| Pension & Post-Retirement Benefits | 1,475 | 1,462 | 1,439 | 1,544 | 1,563 | Upgrade
|
| Other Long-Term Liabilities | 5 | 7 | 5 | 138.1 | 272.34 | Upgrade
|
| Total Liabilities | 4,747 | 5,012 | 5,031 | 4,982 | 4,247 | Upgrade
|
| Common Stock | 3,395 | 3,395 | 3,396 | 3,396 | 3,396 | Upgrade
|
| Additional Paid-In Capital | 2,675 | 2,675 | 2,676 | 2,676 | 2,676 | Upgrade
|
| Retained Earnings | 5,902 | 6,124 | 6,708 | 6,831 | 6,652 | Upgrade
|
| Treasury Stock | -13 | -10 | -192.54 | -174.87 | -160.31 | Upgrade
|
| Comprehensive Income & Other | 143 | -20 | 86.82 | 34.9 | 307.07 | Upgrade
|
| Shareholders' Equity | 12,102 | 12,164 | 12,674 | 12,763 | 12,871 | Upgrade
|
| Total Liabilities & Equity | 16,849 | 17,176 | 17,705 | 17,745 | 17,118 | Upgrade
|
| Total Debt | 1,657 | 1,471 | 1,651 | 29.06 | - | Upgrade
|
| Net Cash (Debt) | 212 | 156 | 297.54 | 2,434 | 3,765 | Upgrade
|
| Net Cash Growth | 35.90% | -47.57% | -87.78% | -35.35% | 16.28% | Upgrade
|
| Net Cash Per Share | 6.09 | 4.51 | 8.65 | 70.66 | 111.06 | Upgrade
|
| Filing Date Shares Outstanding | 34.79 | 34.81 | 34.38 | 34.43 | 34.47 | Upgrade
|
| Total Common Shares Outstanding | 34.79 | 34.81 | 34.38 | 34.43 | 34.47 | Upgrade
|
| Working Capital | 6,372 | 5,921 | 5,937 | 5,576 | 7,599 | Upgrade
|
| Book Value Per Share | 347.83 | 349.47 | 368.67 | 370.70 | 373.38 | Upgrade
|
| Tangible Book Value | 11,694 | 12,057 | 12,555 | 12,632 | 12,711 | Upgrade
|
| Tangible Book Value Per Share | 336.11 | 346.40 | 365.22 | 366.88 | 368.75 | Upgrade
|
| Land | - | - | 337.24 | 337.24 | 337.24 | Upgrade
|
| Construction In Progress | - | - | 27.8 | 1,990 | 436 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.